With a market cap of $53.9 billion, Edwards Lifesciences Corporation (EW) is a global leader in structural heart innovation, dedicated to improving patient lives through breakthrough medical technologies and evidence-based solutions. Driven by a patient-focused culture and strong…This story appeared on barchart.com , 2026-08-12 13:01:14.